Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Call for papers: New technology applications in health and disease
Submit to our upcoming special issue guest edited by Fei Chen and Francisco De La Vega.
Coronavirus Resource - Submit your latest research and discoveries
Genome Medicine is pleased to present its Coronavirus Resource guest edited by Junhua Li.
Special issue: Targeting cancer evolution in the clinic
Our special issue on ‘Targeting cancer evolution in the clinic’, guest-edited by Razelle Kurzrock and Alberto Bardelli, has now launched.
Call for papers: Dissecting the role of immune responses in complex brain disorders
Submit to our upcoming special issue guest edited by Philip de Jager and Carlos Cruchaga.
Reviews, Research Highlights and Commentaries
Articles
-
-
Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors
-
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
-
Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome
-
Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
The Human Genome Project: big science transforms biology and medicine
-
Gut microbiome-host interactions in health and disease
-
Best practices for variant calling in clinical sequencing
Focus: The human microbiome in health and disease
Read the latest Research and and Reviews on the human microbiome in health and disease:
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides
Langdon, A., Schwartz, D.J., Bulow, C. et al. Genome Med 13, 28 (2021)
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, E., Jenq, R.R. Genome Med 13, 107 (2021)
Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L.H., Franzosa, E.A. et al. Genome Med 12, 71 (2020).
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
Usyk, M., Pandey, A., Hayes, R.B. et al. Genome Med 13, 160 (2021).
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
The impact of genomics on precision public health
Guest editors: Muin Khoury and Kathryn Holt
Special issue
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
- Identity transparency: Single anonymized
- Reviewer interacts with: Editor
- Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
From the blog
- Editorial Board
- Editorial Team
- Call for EBMs
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
Annual Journal Metrics
-
Citation Impact
15.266 - 2-year Impact Factor (2021)
15.579 - 5-year Impact Factor (2021)
2.245 - Source Normalized Impact per Paper (SNIP)
5.564 - SCImago Journal Rank (SJR)Speed
8 days to first decision for all manuscripts (Median)
59 days to first decision for reviewed manuscripts only (Median)Usage
1,690,990 Downloads (2021)
4436 Altmetric mentions (2021)